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Summary In western countries, the use of a balloon-expandable covered stent is recom-
mended for the treatment of native coarctation of the aorta (CoA) in adult patients because
endovascular bare stents cannot completely prevent complications such as aneurysms or aortic
rupture. However, such a product that is appropriate and ofﬁcially approved is not available in
Japan. We developed and used a handmade balloon-expandable covered stent in a 32-year-old
patient with native CoA and achieved a good outcome. A Palmaz-Schatz stent (XL 10-series
4010; Johnson & Johnson, Warren, NJ, USA) was covered with an Ube woven-graft (WST series;
18mm across; Ube Junken Medical, Tokyo, Japan). Because the stent shortens when dilated,
one end of the graft was ﬁrmly sutured to one end of the stent, whereas the other end of the
graft was stitched loosely to the other end of the stent so that it could slide along the struts of
the stent to accommodate foreshortening. After meticulous in vitro simulations, the covered
stent was implanted with right ventricular overdrive pacing. No complications were observed,
and the pressure gradient disapp
expandable covered stent is high
and hopefully in children.
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ly safe and effective for correcting native CoA in adult patients
diology. Published by Elsevier Ireland Ltd. All rights reserved.
& Cardiovascular Center, Ehime University Hospital, Shitsukawa,
1.
Published by Elsevier Ireland Ltd. All rights reserved.
2 T. Higaki et al.
I
B
b
r
a
a
[
t
f
r
e
i
c
c
i
r
w
e
i
C
A
h
w
u
a
h
b
b
a
a
a
t
o
m
n
d
t
s
5
e
h
e
t
4
L
i
t
i
a
t
C
t
m
t
b
Figure 1 Cardiac magnetic resonance imaging in the patient.
(A) The isthmus was mildly hypoplastic (diameter, 11mm). (B)
The smallest diameter of the coarctation of the aorta (CoA)
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ntroduction
alloon-expandable endovascular stent implantation has
ecome an accepted modality for treatment of native and
ecurrent coarctation of the aorta (CoA) in adolescents and
dults [1]. However, even with these stents, aneurysms or
ortic ruptures may occur as major acute complications
2—5].
In patients at a high risk of Turner’s syndrome or hypoplas-
ic aortic arch, and in adult patients suspected to have
ragile blood vessels, treatment with a covered stent is
ecommended for safety purposes [6,7]. However, a balloon-
xpandable covered stent is not available in Japan. Hence,
t is necessary to develop an appropriate covered stent for
linical use.
Recently, we developed a handmade balloon-expandable
overed stent in collaboration with a company, and used
t for an adult patient with native CoA. This is the ﬁrst
eport describing a case in which a successful implantation
as achieved using a handmade balloon-expandable cov-
red stent for transcatheter treatment of CoA in a patient
n Japan.
ase histories
32-year-old female patient who showed no symptoms of
ypertension was diagnosed with hypertension when she
as aged 20 years, and had been regularly followed up
nder the diagnosis of essential hypertension. When she was
ged 29 years, she underwent further examination during
er pregnancy. Her blood pressure (BP) was found to vary
etween the upper and lower extremities and was detected
y ankle brachial index examination. The BP in the upper
nd lower extremities was 150/79mmHg (mean, 112mmHg)
nd 94/67mmHg (mean, 80mmHg), respectively, showing
pressure gradient of approximately 60mmHg between
he upper and lower extremities. No difference in BP was
bserved between the right and left extremities. A systolic
urmur of Levine 2/6 was audible at the second left ster-
al border and on the back. Pulsation in the femoral and
orsal pedal arteries was faint. According to these ﬁndings,
he patient was diagnosed with CoA. A chest radiograph
howed mild cardiomegaly with a cardiothoracic ratio of
3%, and left ventricular hypertrophy was observed on an
lectrocardiogram. The echocardiogram showed concentric
ypertrophy of the left ventricle (LV). The left ventricular
nd-diastolic dimension (LVEDD) dilated to 59mm, whereas
he left ventricular ejection fraction (LVEF) decreased to
1%. A ventricular aneurysm was observed at the apex of the
V. Blood ﬂow in the abdominal aorta showed a pattern typ-
cal of CoA. Cardiac magnetic resonance imaging revealed
hat the smallest CoA diameter was 4mm× 3.5mm, and the
sthmus was mildly hypoplastic (diameter, 11mm) (Fig. 1A
nd B). The entire length from the left subclavian artery to
he CoA was 35mm, and the descending aorta distal to the
oA was dilated to 18mm. The patient also had an unrup-
ured cerebral aneurysm of approximately 5mm in the right
iddle cerebral artery.
After taking surgical risk into consideration, we chose
o perform a less invasive treatment using a handmade
alloon-expandable covered stent for the patient; docu-
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tas 4mm× 3.5mm. The entire length from the left subclavian
rtery to the CoA was 35mm, and the descending aorta distal
o the CoA was dilated to 18mm.
ented informed consent was obtained before treatment.
he treatment was approved by the Committee on Clin-
cal Research Ethics (Ehime University Medical Ethics No.
812005).
ethods
Palmaz-Schatz stent (XL 10-series 4010; length, 40mm;
aximum expanded diameter, 25mm; Johnson & Johnson,
arren, NJ, USA) was covered with an Ube woven-graft (WST
eries; 18mm across; Ube Junken Medical, Tokyo, Japan)
Fig. 2). The stent includes 11 struts and when dilated, its
ength reduces by approximately 5mm. Hence, one end of
he graft is ﬁrmly sutured to the end of the stent, whereas
he other end of the graft is stitched loosely to the other
ide of the stent so that it can slide along the struts of the
tent to accommodate foreshortening. Five 6-0 polypropy-
ene needles were also used. Meticulous in vitro simulations
ere performed to conﬁrm that there was no problem with
he system. Because an 18-Fr sheath (Cook, Bloomington, IN,
SA) is necessary to deliver this stent, the femoral artery
as secured by the cut-down method. Subsequently, the
overed stent was mounted on a Mullins balloon catheter
balloon diameter, 12mm; length, 4 cm), and inserted into
he short sheath, which was used as the loader. Because
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Figure 2 Handmade balloon-expandable covered stent. Pal-
maz stent P4010 was covered with an Ube graft (18mm across
in diameter). (A) One end of the graft was ﬁrmly sutured to the
end of the stent (⇒), whereas (B) the other end of the graft was
stitched loosely to the other end of the stent so that it could
Figure 3 Stent implantation by angiographic examination. (A)
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Dslide along the struts of the stent and accommodate foreshort-
ening (→). (C) The manufactured covered stent was mounted
on a Mullins balloon catheter (size, 12mm× 40mm).
the 18-Fr long sheath has no hemostatic valve, a 16-Fr short
sheath was inserted from the back end of the long sheath as
a substitute for a hemostatic valve.Results
Because the distal aortic arch was hypoplastic in this patient
(Fig. 3), the P4010 Palmaz stent, which is long in length,
T
t
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5efore implantation, the narrowest part of the coarctation of
he aorta was 3.5mm. (B) After the implantation, the pressure
radient disappeared.
as the most appropriate choice for dilating the distal aor-
ic arch at the same time. When the stent was expanded,
ight ventricular overdrive pacing was used to prevent the
tent from migrating. An initial balloon size of 12mm was
hosen so that it would not exceed 350% of the narrow-
st portion. The upper and lower ends of the stent were
urther expanded to 15mm, and the shape of the stent
as thus arranged. BP and cardiac function were com-
ared before and after the procedure. The pressure gradient
ecreased from 56mmHg to 2mmHg after the procedure.
onsequently, pressure gradients between the upper and
ower extremities disappeared, and the BP in the upper
ody stabilized. The BP in the right upper extremity was
10/62mmHg (mean, 79mmHg), and that in the right lower
xtremity was 108/64mmHg (mean, 78mmHg). Echocar-
iography revealed that the LVEDD decreased to 54mm,
hereas the LVEF increased to 55%. The temperature in the
atient’s lower extremities increased after the procedure.
efore the procedure, the patient felt that her extremities
ad become cold, and she had easy fatigability.
iscussionhe usefulness of a stent for correcting CoA was reported at
he catheterization and cardiovascular interventions meet-
ng held in 2007 [2]. In this report, it was mentioned that
88 patients were treated between 1989 and 2005 with a
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igh success rate of 98.6%. The complications were as fol-
ows: 2 procedure-related deaths (0.3%) and events such as
tent migration (4.8%), balloon rupture (2.2%), intimal tears
1.3%), aortic dissection (1.5%), aneurysm formation (2.2%),
erebral vascular accident (1.0%), and signiﬁcant femoral
ccess vessel injury (2.6%). After this report, there has been
n increase in the use of the covered stent over the years
6,7]. It is suggested that stent implantation is a safe pro-
edure for patients with severe CoA, including those with
ragile blood vessels as in the case of Turner’s syndrome
8] or with hypoplastic aortic arch, adult patients likely to
xperience greater complications on the aortic wall, and
hose who require treatment and restoration for CoA-related
omplications caused by the use of a conventional stent.
It is said that angioplasty for CoA using a stent should
ot exceed 3.5 times the narrowest diameter [9]; hence, it
s necessary to determine the size of the expanded stent
n which case the use of a balloon-expandable stent is
ppropriate. In addition, this stent can decrease the risk
f the complications on the aortic wall, such as ruptures,
o a greater extent than a self-expandable stent. A self-
xpandable covered stent has been clinically used for aortic
neurysms in adults, and recently, approved products have
ecome available. On the other hand, with regard to a
alloon-expandable covered stent, although the clinical use
f covered Cheatham-platinum stents (NuMed Inc., Hopkin-
on, NY, USA) has been tried, it has not yet been approved
7]. Further, in Japan, suitable stents are not available or
re not approved.
An artiﬁcial blood vessel is required to have sufﬁcient
urability and compatibility with body tissues to be used in
covered stent. The Ube woven-graft that we used in this
tudy is a popular device used for clinically treating thoracic
nd abdominal aneurysms of the aorta. It is important that
he surface of the artiﬁcial vessel grafted to living tissue be
overed with ﬁbrin, and pseudointima formation is observed
uring the healing process. In a previous histological study
n a dog, the membrane of the artiﬁcial blood vessel used
onsisted of compact ﬁbrin, and neointima formation was
bserved [10]. Therefore, this artiﬁcial blood vessel is con-
idered appropriate and sustainable for the treatment of
oA.
This report is valuable because we produced a handmade
alloon-expandable covered stent, used it in a clinical set-
ing, and achieved a satisfactory level of performance.In conclusion, an adult patient with native CoA was
reated with a handmade balloon-expandable covered stent
ithout any complications. This is the ﬁrst report describing
uch a case in Japan. Angioplasty using the balloon-
xpandable covered stent, which we produced, is safe and
[T. Higaki et al.
ffective for correcting CoA in adults. The results indicate
hat the technique used here can be applicable for children
ith CoA in the future.
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